Business
A Stock Analysis Of Biocryst Pharmaceuticals Inc.’s (BCRX)
Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) price on Wednesday, March 27, rose 2.79% above its previous day’s close as an upside momentum from buyers pushed the stock’s
Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) price on Wednesday, March 27, rose 2.79% above its previous day’s close as an upside momentum from buyers pushed the stock’s
Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) concluded the trading at $5.01 on Friday, March 22, with a fall of -8.74% from its closing price on previous day.
Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) traded at $5.36 at close of the session on Tuesday, March 19, made an upward move of 5.72% on its previous
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.